Errin Tablet
Product Images NDC 75907-075

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Errin (NDC 75907-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Labratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Errin 01)

Chemical structure of norethindrone, showing its steroidal framework with hydroxyl, ketone, methyl, and ethynyl functional groups.*

FDA Label Image

Figure (Errin 02)

Weekday dispenser card for Errin 0.35 mg tablets containing norethindrone, USP. The card shows four rows of seven circles each, indicating daily doses with directional arrows and a "Start" label. It includes space to place an enclosed day label, NDC 75907-075-28, and a reminder for monthly self breast exams. The labeler is Dr. Reddy's Laboratories Inc.*

FDA Label Image

Principle-display-panel (Errin 03)

Packaging label for Errin (Norethindrone) Tablets USP 0.35 mg, an oral prescription tablet. The label displays the brand name Errin prominently with the active ingredient and strength noted. It indicates packaging contains 3 blister cards with 28 tablets each. Labeled for distribution by Dr. Reddy's Laboratories Inc. and manufactured by Piramal Healthcare UK Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.